Charter Communications earnings missed by $0.40, revenue was in line with estimates
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX), a $52 billion medical technology company, announced Tuesday that its Board of Directors has declared a quarterly dividend of $1.04 per common share. The dividend will be payable on September 30, 2025, to shareholders of record as of September 8, 2025. According to InvestingPro data, BD has maintained dividend payments for 55 consecutive years, with the current yield at 2.37%.
The medical technology company’s indicated annual dividend rate is $4.16 per share, according to the announcement.
BD, which employs more than 70,000 people worldwide, develops technology, services and solutions for healthcare providers and clinical applications. The company operates in virtually every country globally, focusing on medical discovery, diagnostics and care delivery.
The dividend announcement was made in a press release issued by the company.
In other recent news, Becton Dickinson announced a strategic realignment plan involving the separation of its Biosciences & Diagnostics Solutions division through a merger with Waters Corporation. This $17.5 billion Reverse Morris Trust transaction will see Becton Dickinson receive approximately $4 billion in cash, which the company plans to use for share repurchases and debt reduction. Waters Corporation will assume about $4 billion in incremental debt, resulting in a net-debt-to-adjusted EBITDA ratio of 2.3x for the combined entity.
Additionally, Becton Dickinson has appointed Bilal Muhsin as executive vice president and president of its new Connected Care segment, which aims to enhance patient care efficiency through advanced analytics and AI solutions. Meanwhile, TD Cowen has maintained a Hold rating on Becton Dickinson with a price target of $183, while Stifel analysts have reiterated their Buy rating with a $224 price target. Stifel’s confidence follows a recent investor meeting where CEO Tom Polen addressed the mixed fiscal second-quarter results, which were impacted by macroeconomic challenges. Despite these challenges, the management team expressed a positive outlook for the company’s future.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.